FindTrial
Sign In

Study of gut microbiota to evaluate efficacy of haritaki and amalaki

Study of gut microbiota To evaluate efficacy of haritaki and amalaki.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042914
Enrollment
30
Registered
2022-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Yogita Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Volunteers ready to comply with protocol. 2. Age group ââ?¬â?? 60 years and > 60 years age, irrespective of gender, caste, religion, socio-economic strata, etc. 3. Ready to give informed consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Stool examination-identification of microbial population abundance , comparison of microbial flora from previous sample and after taking study herb sample 16s metagenomics sequencing v3-v4 regionTimepoint: day 0 to 8 th week of study participant—

Secondary

MeasureTime frame
case report form will be analysed for study participants Prakriti, gastrointestinal health and moodTimepoint: 8 weeks.—

Countries

India

Contacts

Public ContactDr Yogita M Chaudhari

Dr D.Y.Patil,College of Ayurveda and research centre,Pimpri

mahismita326@gmail.com9850684960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026